| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e2cac1b8e3b554a7f057949c30d9499 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
1999-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7ce37c67092fdc38e8b3ec8d46ce50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7ab787307aadb136d79c674c5092e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33778ee00a49d67311fa5dcc8625c14 |
| publicationDate |
2002-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6410335-B1 |
| titleOfInvention |
Circulating insulin-like growth factor-I and prostate cancer risk |
| abstract |
Methods of predicting a propensity to developing prostate cancer are presented. The consists of measuring the IGF status of individual. Individuals with high IGF status, as compared with normal reference range values, are at increased risk for developing prostate cancer. More particularly, the IGF status may be determined by measuring IGF-I levels and/or IGFBP-3 levels. High IGF and low IGFBP levels are indicative of a high IGF status. A method of determining the prognosis of existing prostate cancers or of monitoring disease progression involves determining the IGF/PSA status of an individual. Individuals with a high IGF/PSA staus (both high IGF status and high PSA levels) tend to develop severe prostate cancer and have a porrer overall prognosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7725327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005091083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010146059-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009068110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010228570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010235193-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8489416-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005148035-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7348154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7351545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8762164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10776890-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008199886-A1 |
| priorityDate |
1998-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |